Clinical Trial Update: Gonadotropin-releasing Hormone Agonist (GnRHa) Plus Letrozole In Young Women With Early Endometrial Cancer [Phase 2]

View source ↗

Summary

Phase 2 clinical trial evaluating the combination of a gonadotropin-releasing hormone agonist (GnRHa) and letrozole in young women with early-stage endometrial …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Endometrial Cancer

Drugs mentioned

• Gonadotropin-releasing hormone agonist
• Letrozole (letrozole)

Snippet

Sponsor: Fudan University | Conditions: Endometrial Neoplasm Malignant Stage I | Phase 2 | Status: RECRUITING